CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | neonicotinoid insectide |
|
Accession: | CHEBI:25540
|
browse the term
|
Definition: | A class of neuro-active insecticides that act at the nicotinic acetylcholine receptor. |
Synonyms: | related_synonym: | neonicotinoid insectides; nicotinoid insectide; nicotinoid insectides |
| alt_id: | CHEBI:25498 |
| xref: | Wikipedia:Neonicotinoid |
|
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases activity multiple interactions |
EXP |
Thiamethoxam results in increased activity of ALPL protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of ALPL protein] |
CTD |
PMID:30621503 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
Thiamethoxam results in increased expression of ANXA10 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
Ar |
androgen receptor |
affects binding |
ISO |
Thiamethoxam binds to AR protein |
CTD |
PMID:31550567 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of ARG1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Thiamethoxam results in increased expression of ATF3 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Thiamethoxam results in increased expression of BAX protein |
CTD |
PMID:33533595 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of BCL2 protein |
CTD |
PMID:33533595 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of BCL6 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
increases expression |
ISO |
Thiamethoxam results in increased expression of BTG1 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
Thiamethoxam results in increased cleavage of CASP3 protein |
CTD |
PMID:33533595 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
increases expression decreases expression decreases activity multiple interactions |
ISO EXP |
Thiamethoxam results in increased expression of CAT mRNA Thiamethoxam results in decreased expression of CAT mRNA Thiamethoxam results in decreased activity of CAT protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of CAT mRNA] |
CTD |
PMID:30621503 PMID:33533595 PMID:34181816 PMID:36958429 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Thiamethoxam results in increased expression of CCL2 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
Thiamethoxam results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein] |
CTD |
PMID:16981889 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP |
Thiamethoxam results in decreased expression of CYP11A1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:34181816 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP |
Thiamethoxam results in decreased expression of CYP17A1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:34181816 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression multiple interactions increases activity |
ISO EXP |
Thiamethoxam results in increased expression of CYP19A1 mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of CYP19A1 mRNA] Thiamethoxam results in increased activity of CYP19A1 protein |
CTD |
PMID:26464060 PMID:28750898 PMID:34181816 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of CYP2C19 protein |
CTD |
PMID:32194361 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[NADP co-treated with CYP3A4 protein] results in increased activity of Thiamethoxam |
CTD |
PMID:16153789 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of CYP7A1 protein |
CTD |
PMID:32194361 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Thiamethoxam results in increased expression of DDIT3 mRNA; Thiamethoxam results in increased expression of DDIT3 protein |
CTD |
PMID:33533595 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding decreases expression |
ISO |
Thiamethoxam binds to ESR1 protein Thiamethoxam results in decreased expression of ESR1 protein |
CTD |
PMID:31550567 PMID:33533595 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Foxo3 |
forkhead box O3 |
increases expression |
ISO |
Thiamethoxam results in increased expression of FOXO3 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of FSHR protein |
CTD |
PMID:33533595 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of GADD45B mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases activity multiple interactions |
EXP |
Thiamethoxam results in increased activity of GOT1 protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GOT1 protein] |
CTD |
PMID:30621503 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
decreases activity |
EXP |
Thiamethoxam results in decreased activity of GPT protein |
CTD |
PMID:29197058 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression decreases expression decreases activity multiple interactions |
ISO EXP |
Thiamethoxam results in increased expression of GPX1 mRNA Thiamethoxam results in decreased expression of GPX1 mRNA Thiamethoxam results in decreased activity of GPX1 protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of GPX1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of GPX1 mRNA] |
CTD |
PMID:30621503 PMID:33533595 PMID:36958429 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions decreases expression |
EXP |
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of HSD3B1 mRNA] |
CTD |
PMID:34181816 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Thiamethoxam results in increased expression of HSPA5 mRNA; Thiamethoxam results in increased expression of HSPA5 protein |
CTD |
PMID:33533595 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP |
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL1B protein] Thiamethoxam results in increased expression of IL1B mRNA; Thiamethoxam results in increased expression of IL1B protein |
CTD |
PMID:36958429 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of IL6 mRNA] |
CTD |
PMID:36958429 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of ITPR1 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of JUNB mRNA |
CTD |
PMID:33533595 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Ldha |
lactate dehydrogenase A |
increases activity multiple interactions |
EXP |
Thiamethoxam results in increased activity of LDHA protein [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of LDHA protein] |
CTD |
PMID:30621503 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression multiple interactions increases expression |
ISO EXP |
Thiamethoxam results in decreased expression of LHCGR protein Plant Extracts inhibits the reaction [Thiamethoxam results in increased expression of LHCGR mRNA] |
CTD |
PMID:33533595 PMID:34181816 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lst1 |
leukocyte specific transcript 1 |
increases expression |
ISO |
Thiamethoxam results in increased expression of LST1 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
|
|
G |
Mc4r |
melanocortin 4 receptor |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of MC4R mRNA |
CTD |
PMID:33533595 |
|
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
increases expression |
ISO |
Thiamethoxam results in increased expression of MMP7 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases activity multiple interactions increases expression |
ISO EXP |
Thiamethoxam metabolite results in decreased activity of NOS2 protein Silymarin inhibits the reaction [Thiamethoxam results in increased expression of NOS2 mRNA] [Thiamethoxam metabolite results in decreased activity of NOS2 protein] which results in increased chemical synthesis of Formaldehyde |
CTD |
PMID:29197058 PMID:36958429 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Plcg2 |
phospholipase C, gamma 2 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of PLCG2 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr19:45,547,416...45,683,930
Ensembl chr19:45,547,416...45,683,930
|
|
G |
Prnp |
prion protein |
increases expression |
ISO |
Thiamethoxam results in increased expression of PRNP mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of PTGS2 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of PTHLH mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Ptx3 |
pentraxin 3 |
increases expression |
ISO |
Thiamethoxam results in increased expression of PTX3 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions decreases expression |
EXP |
Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of SCARB1 mRNA] |
CTD |
PMID:34181816 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Sesn2 |
sestrin 2 |
increases expression |
ISO |
Thiamethoxam results in increased expression of SESN2 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases activity |
ISO |
Thiamethoxam results in decreased activity of SLC22A2 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Thiamethoxam results in increased expression of SLC7A11 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity decreases expression multiple interactions |
EXP |
Thiamethoxam results in decreased activity of SOD1 protein Thiamethoxam results in decreased expression of SOD1 mRNA [fenugreek seed meal results in increased abundance of Polysaccharides] inhibits the reaction [Thiamethoxam results in decreased activity of SOD1 protein]; Silymarin inhibits the reaction [Thiamethoxam results in decreased expression of SOD1 mRNA] |
CTD |
PMID:30621503 PMID:36958429 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression multiple interactions |
EXP |
Thiamethoxam results in decreased expression of STAR mRNA Plant Extracts inhibits the reaction [Thiamethoxam results in decreased expression of STAR mRNA] |
CTD |
PMID:34181816 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stc2 |
stanniocalcin 2 |
increases expression |
ISO |
Thiamethoxam results in increased expression of STC2 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
|
|
G |
Thbs4 |
thrombospondin 4 |
decreases expression |
ISO |
Thiamethoxam results in decreased expression of THBS4 mRNA |
CTD |
PMID:33533595 |
|
NCBI chr 2:23,983,158...24,025,289
Ensembl chr 2:23,983,158...24,026,313
|
|
G |
Thra |
thyroid hormone receptor alpha |
affects binding |
ISO |
Thiamethoxam binds to THRA protein |
CTD |
PMID:31550567 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF mRNA]; Silymarin inhibits the reaction [Thiamethoxam results in increased expression of TNF protein] Thiamethoxam results in increased expression of TNF mRNA; Thiamethoxam results in increased expression of TNF protein |
CTD |
PMID:36958429 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
increases secretion multiple interactions |
EXP |
Thiamethoxam results in increased secretion of TNNT2 protein fenugreek seed meal inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein]; Polysaccharides inhibits the reaction [Thiamethoxam results in increased secretion of TNNT2 protein] |
CTD |
PMID:30520268 |
|
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
|
|
|
G |
Ache |
acetylcholinesterase |
increases activity multiple interactions |
EXP |
acetamiprid results in increased activity of ACHE protein Berberine inhibits the reaction [acetamiprid results in increased activity of ACHE protein] |
CTD |
PMID:37350525 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Actrt2 |
actin-related protein T2 |
decreases expression |
EXP |
acetamiprid results in decreased expression of ACTRT2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 5:165,236,092...165,237,492
Ensembl chr 5:165,236,086...165,237,629
|
|
G |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
increases expression |
EXP |
acetamiprid results in increased expression of ASAP2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975
|
|
G |
B3gnt9 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
increases expression |
EXP |
acetamiprid results in increased expression of B3GNT9 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr19:33,129,740...33,134,048
Ensembl chr19:33,128,142...33,132,344
|
|
G |
Bche |
butyrylcholinesterase |
increases activity |
EXP |
acetamiprid results in increased activity of BCHE protein |
CTD |
PMID:38011675 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
ISO |
acetamiprid results in increased expression of BCL2 protein |
CTD |
PMID:36457797 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
increases expression |
EXP |
acetamiprid results in increased expression of CACNA1H mRNA |
CTD |
PMID:27782041 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Cacng1 |
calcium voltage-gated channel auxiliary subunit gamma 1 |
decreases expression |
EXP |
acetamiprid results in decreased expression of CACNG1 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr10:92,652,924...92,665,612
Ensembl chr10:92,652,614...92,665,783
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
increases expression |
EXP |
acetamiprid results in increased expression of CARD11 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
ISO EXP |
acetamiprid results in decreased activity of CAT protein Berberine inhibits the reaction [acetamiprid results in decreased activity of CAT protein] |
CTD |
PMID:31935421 PMID:37350525 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
decreases expression |
ISO |
acetamiprid results in decreased expression of CHRNA4 mRNA |
CTD |
PMID:30103633 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
decreases expression |
ISO |
acetamiprid results in decreased expression of CHRNA7 mRNA |
CTD |
PMID:30103633 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
decreases expression multiple interactions |
ISO EXP |
acetamiprid results in decreased expression of CHRNB2 acetamiprid results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]; acetamiprid results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein] |
CTD |
PMID:16981889 PMID:25459289 PMID:27669271 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
decreases expression multiple interactions |
EXP |
acetamiprid results in decreased expression of COX4I1 mRNA Berberine inhibits the reaction [acetamiprid results in decreased expression of COX4I1 mRNA] |
CTD |
PMID:37350525 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
EXP ISO |
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein] acetamiprid results in decreased expression of CYP11A1 mRNA acetamiprid results in decreased expression of CYP11A1 mRNA; acetamiprid results in decreased expression of CYP11A1 protein |
CTD |
PMID:28395332 PMID:30103633 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
acetamiprid results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:30103633 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Dcdc2 |
doublecortin domain containing 2 |
increases expression decreases expression |
EXP |
acetamiprid results in increased expression of DCDC2 mRNA acetamiprid results in decreased expression of DCDC2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr17:39,845,952...40,031,781
Ensembl chr17:39,845,952...40,030,743
|
|
G |
Des |
desmin |
decreases expression |
EXP |
acetamiprid results in decreased expression of DES mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
increases expression |
EXP |
acetamiprid results in increased expression of F2RL2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098
|
|
G |
Fasn |
fatty acid synthase |
increases expression multiple interactions |
EXP |
acetamiprid results in increased expression of FASN protein Folic Acid inhibits the reaction [acetamiprid results in increased expression of FASN protein] |
CTD |
PMID:35124148 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP |
acetamiprid results in increased activity of GPT protein Folic Acid inhibits the reaction [acetamiprid results in increased activity of GPT protein] |
CTD |
PMID:35124148 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
decreases expression |
EXP |
acetamiprid results in decreased expression of GRIN1 mRNA |
CTD |
PMID:33523378 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
decreases expression |
EXP |
acetamiprid results in decreased expression of GRIN2A mRNA |
CTD |
PMID:33523378 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
decreases expression |
EXP |
acetamiprid results in decreased expression of GRIN2B mRNA |
CTD |
PMID:33523378 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
ISO |
acetamiprid results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:30103633 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hspb7 |
heat shock protein family B (small) member 7 |
decreases expression |
EXP |
acetamiprid results in decreased expression of HSPB7 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
|
|
G |
Iqcf1 |
IQ motif containing F1 |
decreases expression |
EXP |
acetamiprid results in decreased expression of IQCF1 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 8:107,129,462...107,133,242
Ensembl chr 8:107,130,704...107,133,249
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions increases expression |
EXP |
Vitamin E inhibits the reaction [acetamiprid results in increased expression of LHB protein] |
CTD |
PMID:28395332 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression |
ISO |
acetamiprid results in decreased expression of LHR mRNA |
CTD |
PMID:30103633 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lmod2 |
leiomodin 2 |
decreases expression |
EXP |
acetamiprid results in decreased expression of LMOD2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 4:53,067,428...53,075,124
Ensembl chr 4:53,067,428...53,075,120
|
|
G |
Mb |
myoglobin |
decreases expression |
EXP |
acetamiprid results in decreased expression of MB mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mcmdc2 |
minichromosome maintenance domain containing 2 |
increases expression |
EXP |
acetamiprid results in increased expression of MCMDC2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 5:9,291,967...9,337,526
Ensembl chr 5:9,298,101...9,338,300
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
acetamiprid results in decreased expression of MKI67 mRNA |
CTD |
PMID:30103633 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
decreases expression multiple interactions |
EXP |
acetamiprid results in decreased expression of COX1 mRNA Berberine inhibits the reaction [acetamiprid results in decreased expression of COX1 mRNA] |
CTD |
PMID:37350525 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
multiple interactions decreases expression |
EXP |
Berberine inhibits the reaction [acetamiprid results in decreased expression of ND1 mRNA] |
CTD |
PMID:37350525 |
|
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
decreases expression multiple interactions |
EXP |
acetamiprid results in decreased expression of ND2 mRNA Berberine inhibits the reaction [acetamiprid results in decreased expression of ND2 mRNA] |
CTD |
PMID:37350525 |
|
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Myog |
myogenin |
decreases expression |
EXP |
acetamiprid results in decreased expression of MYOG mRNA |
CTD |
PMID:27782041 |
|
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
|
|
G |
Nags |
N-acetylglutamate synthase |
decreases expression |
EXP |
acetamiprid results in decreased expression of NAGS mRNA |
CTD |
PMID:27782041 |
|
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
|
|
G |
Napb |
NSF attachment protein beta |
increases expression |
EXP |
acetamiprid results in increased expression of NAPB mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
|
|
G |
Ndufaf2 |
NADH:ubiquinone oxidoreductase complex assembly factor 2 |
decreases expression |
EXP |
acetamiprid results in decreased expression of NDUFAF2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 2:39,535,680...39,647,378
Ensembl chr 2:39,535,689...39,647,316
|
|
G |
Or52s20 |
olfactory receptor family 52 subfamily S member 20 |
decreases expression |
EXP |
acetamiprid results in decreased expression of OR52S20 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 1:157,748,451...157,749,422
Ensembl chr 1:157,748,451...157,749,422
|
|
G |
Or6d13b |
olfactory receptor family 6 subfamily D member 13B |
decreases expression |
EXP |
acetamiprid results in decreased expression of OR6D13B mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 4:149,673,586...149,674,569
Ensembl chr 4:149,669,618...149,678,130
|
|
G |
Phf21b |
PHD finger protein 21B |
increases expression |
EXP |
acetamiprid results in increased expression of PHF21B mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 7:115,913,704...115,984,215
Ensembl chr 7:115,915,412...115,984,215
|
|
G |
Plac8 |
placenta associated 8 |
increases expression |
EXP |
acetamiprid results in increased expression of PLAC8 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
increases activity |
ISO |
acetamiprid results in increased activity of SLC22A1 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases activity |
ISO |
acetamiprid results in decreased activity of SLC22A2 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases activity |
ISO |
acetamiprid results in decreased activity of SLC22A8 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc45a3 |
solute carrier family 45, member 3 |
increases expression |
EXP |
acetamiprid results in increased expression of SLC45A3 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
decreases expression |
EXP |
acetamiprid results in decreased expression of SLCO1B2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression multiple interactions |
EXP |
acetamiprid results in decreased expression of SOD2 mRNA Berberine inhibits the reaction [acetamiprid results in decreased expression of SOD2 mRNA] |
CTD |
PMID:37350525 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression multiple interactions |
EXP ISO |
acetamiprid results in decreased expression of STAR mRNA; acetamiprid results in decreased expression of STAR protein Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR protein] |
CTD |
PMID:28395332 PMID:30103633 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tada2b |
transcriptional adaptor 2B |
increases expression |
EXP |
acetamiprid results in increased expression of TADA2B mRNA |
CTD |
PMID:27782041 |
|
NCBI chr14:74,279,286...74,290,758
Ensembl chr14:74,279,217...74,290,755
|
|
G |
Tnni2 |
troponin I2, fast skeletal type |
decreases expression |
EXP |
acetamiprid results in decreased expression of TNNI2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 1:197,595,012...197,597,554
Ensembl chr 1:197,594,813...197,597,560
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases expression |
ISO |
acetamiprid results in decreased expression of TOP2A mRNA |
CTD |
PMID:30103633 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
acetamiprid results in increased expression of TP53 protein |
CTD |
PMID:36457797 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Unc45b |
unc-45 myosin chaperone B |
decreases expression |
EXP |
acetamiprid results in decreased expression of UNC45B mRNA |
CTD |
PMID:27782041 |
|
NCBI chr10:67,845,464...67,873,143
Ensembl chr10:67,845,462...67,873,389
|
|
|
G |
Abca13 |
ATP binding cassette subfamily A member 13 |
increases expression |
ISO |
clothianidin results in increased expression of ABCA13 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr14:83,873,397...84,376,138
Ensembl chr14:83,873,940...84,375,075
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
decreases expression |
ISO |
clothianidin results in decreased expression of ABCB6 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
clothianidin results in increased expression of ABCC1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions increases expression |
EXP |
[enilconazole co-treated with clothianidin] results in increased expression of ABCC3 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of ABCC3 mRNA clothianidin results in increased expression of ABCC3 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of ABCD2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of ABCD3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of ABCG1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
decreases expression |
ISO |
clothianidin results in decreased expression of ABHD4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
decreases expression |
ISO |
clothianidin results in decreased expression of ABI3BP mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Ache |
acetylcholinesterase |
decreases expression |
ISO |
clothianidin results in decreased expression of ACHE mRNA |
CTD |
PMID:35264496 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adcy2 |
adenylate cyclase 2 |
increases expression |
ISO |
clothianidin results in increased expression of ADCY2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236
|
|
G |
Adcy4 |
adenylate cyclase 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of ADCY4 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
decreases expression |
ISO |
clothianidin results in decreased expression of ADGRB2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
decreases expression |
ISO |
clothianidin results in decreased expression of ADGRF5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
decreases expression |
ISO |
clothianidin results in decreased expression of ADGRG6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of ADRB2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Agbl3 |
AGBL carboxypeptidase 3 |
increases expression |
ISO |
clothianidin results in increased expression of AGBL3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:63,448,789...63,535,538
Ensembl chr 4:63,453,940...63,531,188
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
increases expression |
ISO |
clothianidin results in increased expression of AKR1B7 mRNA |
CTD |
PMID:33563863 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression multiple interactions |
EXP |
clothianidin results in increased expression of ALDH1A1 mRNA [enilconazole co-treated with clothianidin] results in increased expression of ALDH1A1 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Amz1 |
archaelysin family metallopeptidase 1 |
increases expression |
ISO |
clothianidin results in increased expression of AMZ1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
|
|
G |
Ank3 |
ankyrin 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of ANK3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
decreases expression |
ISO |
clothianidin results in decreased expression of ANKRD37 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Aplf |
aprataxin and PNKP like factor |
increases expression |
ISO |
clothianidin results in increased expression of APLF mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Arhgap17 |
Rho GTPase activating protein 17 |
increases expression |
ISO |
clothianidin results in increased expression of ARHGAP17 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
ISO |
clothianidin results in increased expression of ARHGEF2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arl11 |
ARF like GTPase 11 |
increases expression |
ISO |
clothianidin results in increased expression of ARL11 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:35,483,330...35,485,579
Ensembl chr15:35,480,018...35,496,596
|
|
G |
Arl14 |
ARF like GTPase 14 |
increases expression |
ISO |
clothianidin results in increased expression of ARL14 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 2:153,468,863...153,470,102
Ensembl chr 2:153,468,977...153,469,555
|
|
G |
Arl6 |
ARF like GTPase 6 |
increases expression |
ISO |
clothianidin results in increased expression of ARL6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:40,711,878...40,738,254
Ensembl chr11:40,712,022...40,737,937
|
|
G |
Asb11 |
ankyrin repeat and SOCS box containing 11 |
increases expression |
ISO |
clothianidin results in increased expression of ASB11 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:30,014,485...30,037,808
Ensembl chr X:29,992,416...30,037,807
|
|
G |
Asphd1 |
aspartate beta-hydroxylase domain containing 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of ASPHD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:181,552,968...181,556,902
Ensembl chr 1:181,552,884...181,556,090
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of ATP1A2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp23 |
ATP23 metallopeptidase and ATP synthase assembly factor homolog |
increases expression |
ISO |
clothianidin results in increased expression of XRCC6BP1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:62,714,752...62,729,893
Ensembl chr 7:62,714,785...62,729,862
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of ATP2B3 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
increases expression |
ISO |
clothianidin results in increased expression of ATP6V0D2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
|
|
G |
Awat1 |
acyl-CoA wax alcohol acyltransferase 1 |
increases expression |
ISO |
clothianidin results in increased expression of AWAT1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:65,668,205...65,674,450
Ensembl chr X:65,668,205...65,674,450
|
|
G |
Axin1 |
axin 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of AXIN1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Azin2 |
antizyme inhibitor 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of AZIN2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 5:141,281,310...141,310,415
Ensembl chr 5:141,281,249...141,310,397
|
|
G |
Barhl1 |
BarH-like homeobox 1 |
increases expression |
ISO |
clothianidin results in increased expression of BARHL1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:12,241,327...12,248,649
Ensembl chr 3:12,241,327...12,248,649
|
|
G |
Bcr |
BCR activator of RhoGEF and GTPase |
decreases expression |
ISO |
clothianidin results in decreased expression of BCR mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:13,469,325...13,596,942
Ensembl chr20:13,471,668...13,597,016
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of BICD2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr17:15,259,773...15,304,889
Ensembl chr17:15,259,773...15,304,889
|
|
G |
Bricd5 |
BRICHOS domain containing 5 |
decreases expression |
ISO |
clothianidin results in decreased expression of BRICD5 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:13,498,726...13,500,259
Ensembl chr10:13,498,381...13,500,259
|
|
G |
C11h21orf140 |
similar to human chromosome 21 open reading frame 140 |
increases expression |
ISO |
clothianidin results in increased expression of C21ORF140 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:31,549,689...31,552,257
Ensembl chr11:31,544,426...31,552,290
|
|
G |
C14H22orf31 |
chromosome 14 C22orf31 homolog |
decreases expression |
ISO |
clothianidin results in decreased expression of C22ORF31 mRNA |
CTD |
PMID:31626844 |
|
|
|
G |
C14h4orf36 |
similar to human chromosome 4 open reading frame 36 |
decreases expression |
ISO |
clothianidin results in decreased expression of C4ORF36 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr14:6,058,581...6,065,848
Ensembl chr14:6,058,581...6,065,847
|
|
G |
C18h5orf46 |
similar to human chromosome 5 open reading frame 46 |
increases expression |
ISO |
clothianidin results in increased expression of C5ORF46 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:35,948,402...35,969,502
Ensembl chr18:35,948,402...35,969,502
|
|
G |
C19h16orf74 |
similar to human chromosome 16 open reading frame 74 |
decreases expression |
ISO |
clothianidin results in decreased expression of C16ORF74 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:48,660,288...48,686,287
Ensembl chr19:48,660,288...48,686,349
|
|
G |
C20h21orf58 |
similar to human chromosome 21 open reading frame 58 |
decreases expression |
ISO |
clothianidin results in decreased expression of C21ORF58 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:12,167,279...12,188,665
Ensembl chr20:12,175,442...12,187,017
|
|
G |
C2cd4b |
C2 calcium-dependent domain containing 4B |
increases expression |
ISO |
clothianidin results in increased expression of C2CD4B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:68,372,793...68,396,477
Ensembl chr 8:68,384,847...68,396,328
|
|
G |
C2h5orf34 |
similar to human chromosome 5 open reading frame 34 |
increases expression |
ISO |
clothianidin results in increased expression of C5ORF34 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 2:51,553,223...51,577,090
Ensembl chr 2:51,555,432...51,577,085
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of CACNB2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Calhm3 |
calcium homeostasis modulator 3 |
increases expression |
ISO |
clothianidin results in increased expression of CALHM3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:246,043,258...246,048,259
Ensembl chr 1:246,043,258...246,048,259
|
|
G |
Capn5 |
calpain 5 |
increases expression |
ISO |
clothianidin results in increased expression of CAPN5 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923
|
|
G |
Caps |
calcyphosine |
decreases expression |
ISO |
clothianidin results in decreased expression of CAPS mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 9:1,544,597...1,545,631
Ensembl chr 9:1,544,719...1,545,647
|
|
G |
Car3 |
carbonic anhydrase 3 |
increases expression |
ISO |
clothianidin results in increased expression of CA3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of CARMIL1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr17:40,807,921...41,088,326
Ensembl chr17:40,808,389...41,088,326
|
|
G |
Carmil3 |
capping protein regulator and myosin 1 linker 3 |
increases expression |
ISO |
clothianidin results in increased expression of CARMIL3 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225
|
|
G |
Ccdc17 |
coiled-coil domain containing 17 |
decreases expression |
ISO |
clothianidin results in decreased expression of CCDC17 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 5:130,051,158...130,056,676
Ensembl chr 5:130,045,938...130,056,673
|
|
G |
Ccdc8 |
coiled-coil domain containing 8 |
increases expression |
ISO |
clothianidin results in increased expression of CCDC8 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:77,679,521...77,682,849
Ensembl chr 1:77,679,218...77,683,090
|
|
G |
Ccser1 |
coiled-coil serine-rich protein 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of CCSER1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
|
|
G |
Cd226 |
CD226 molecule |
decreases expression |
ISO |
clothianidin results in decreased expression of CD226 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051
|
|
G |
Cd34 |
CD34 molecule |
increases expression |
ISO |
clothianidin results in increased expression of CD34 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
ISO |
clothianidin results in increased expression of CD74 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd8b |
CD8 subunit beta |
increases expression |
ISO |
clothianidin results in increased expression of CD8B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:103,312,596...103,328,523
Ensembl chr 4:103,312,578...103,328,553
|
|
G |
Cdh8 |
cadherin 8 |
decreases expression |
ISO |
clothianidin results in decreased expression of CDH8 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669
|
|
G |
Cdrt15l2 |
CMT1A duplicated region transcript 15 like 2 |
increases expression |
ISO |
clothianidin results in increased expression of CDRT15L2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:11,226,012...11,231,967
Ensembl chr16:11,122,718...11,158,623
|
|
G |
Ceacam6 |
CEA cell adhesion molecule 6 |
increases expression |
ISO |
clothianidin results in increased expression of CEACAM6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:80,416,531...80,434,668
|
|
G |
Cemip |
cell migration inducing hyaluronidase 1 |
increases expression |
ISO |
clothianidin results in increased expression of CEMIP mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
|
|
G |
Ces2h |
carboxylesterase 2H |
multiple interactions |
ISO |
[clothianidin co-treated with thiacloprid] results in increased expression of CES2 protein |
CTD |
PMID:32201337 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cfap107 |
cilia and flagella associated protein 107 |
decreases expression |
ISO |
clothianidin results in decreased expression of CFAP107 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:156,212,385...156,231,481
Ensembl chr 5:156,212,385...156,231,481
|
|
G |
Chat |
choline O-acetyltransferase |
decreases expression |
ISO |
clothianidin results in decreased expression of CHAT mRNA |
CTD |
PMID:35264496 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:21538459 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
decreases expression |
ISO |
clothianidin results in decreased expression of CHRNA7 mRNA |
CTD |
PMID:35264496 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP ISO |
clothianidin results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]; clothianidin results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein] clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:16981889 PMID:21538459 PMID:25459289 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
increases expression |
ISO |
clothianidin results in increased expression of CHST3 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807
|
|
G |
Cldn14 |
claudin 14 |
decreases expression |
ISO |
clothianidin results in decreased expression of CLDN14 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
|
|
G |
Clec3b |
C-type lectin domain family 3, member B |
increases expression |
ISO |
clothianidin results in increased expression of CLEC3B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:122,810,120...122,815,837
Ensembl chr 8:122,810,149...122,815,835
|
|
G |
Cmtm5 |
CKLF-like MARVEL transmembrane domain containing 5 |
increases expression |
ISO |
clothianidin results in increased expression of CMTM5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:28,412,624...28,415,304
Ensembl chr15:28,412,624...28,415,287
|
|
G |
Cntnap1 |
contactin associated protein 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of CNTNAP1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:86,109,850...86,125,612
Ensembl chr10:86,111,643...86,125,611
|
|
G |
Col12a1 |
collagen type XII alpha 1 chain |
decreases expression |
ISO |
clothianidin results in decreased expression of COL12A1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:80,547,592...80,665,665
Ensembl chr 8:80,547,593...80,665,686
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
clothianidin results in decreased expression of COL1A1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
clothianidin results in decreased expression of COL5A2 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
clothianidin results in increased expression of COL6A2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
decreases expression |
ISO |
clothianidin results in decreased expression of COL7A1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Coro2b |
coronin 2B |
decreases expression |
ISO |
clothianidin results in decreased expression of CORO2B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:62,906,861...63,017,295
Ensembl chr 8:62,906,867...63,017,302
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of CPEB3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Cpne4 |
copine 4 |
increases expression |
ISO |
clothianidin results in increased expression of CPNE4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:105,177,376...105,653,075
Ensembl chr 8:105,177,376...105,653,068
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
increases expression |
ISO |
clothianidin results in increased expression of CSMD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
increases expression |
ISO |
clothianidin results in increased expression of CXADR mRNA |
CTD |
PMID:29044138 |
|
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
ISO |
clothianidin results in decreased expression of CYBA mRNA |
CTD |
PMID:35690182 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
affects expression |
ISO |
clothianidin affects the expression of CYP19A1 mRNA |
CTD |
PMID:33563863 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression |
ISO |
[clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA clothianidin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:32201337 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[clothianidin co-treated with enilconazole] results in increased expression of CYP1B1 protein |
CTD |
PMID:32201337 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression multiple interactions |
EXP |
clothianidin results in increased expression of CYP2B2 mRNA [enilconazole co-treated with clothianidin] results in increased expression of CYP2B2 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of CYP2B2 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[clothianidin co-treated with thiacloprid] results in increased expression of CYP2B6 protein |
CTD |
PMID:32201337 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression multiple interactions |
ISO |
clothianidin results in decreased expression of CYP2E1 mRNA [clothianidin co-treated with enilconazole] results in decreased expression of CYP2E1 mRNA; [clothianidin co-treated with thiacloprid] results in increased expression of CYP2E1 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:32201337 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression multiple interactions |
ISO |
clothianidin results in increased expression of CYP3A4 mRNA [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 mRNA; [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 protein; [clothianidin co-treated with thiacloprid] results in increased expression of CYP3A4 protein; [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP3A4 mRNA |
CTD |
PMID:32201337 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions increases expression |
EXP |
[enilconazole co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A23-3A1 mRNA clothianidin results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions increases expression |
ISO |
[clothianidin co-treated with enilconazole] results in increased expression of CYP3A5 protein; [thiacloprid co-treated with clothianidin] results in increased expression of CYP3A5 mRNA clothianidin results in increased expression of CYP3A5 mRNA |
CTD |
PMID:32201337 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions decreases expression |
EXP |
[enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA clothianidin results in decreased expression of CYP7A1 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyth4 |
cytohesin 4 |
increases expression |
ISO |
clothianidin results in increased expression of CYTH4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of DACT1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
|
|
G |
Defa5 |
defensin alpha 5 |
decreases expression |
ISO |
clothianidin results in decreased expression of DEFA5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
|
|
G |
Des |
desmin |
increases expression |
ISO |
clothianidin results in increased expression of DES mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Dgkd |
diacylglycerol kinase, delta |
increases expression |
ISO |
clothianidin results in increased expression of DGKD mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
increases expression |
ISO |
clothianidin results in increased expression of DIO3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of DLL3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dnai7 |
dynein axonemal intermediate chain 7 |
decreases expression |
ISO |
clothianidin results in decreased expression of DNAI7 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980
|
|
G |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
increases expression |
ISO |
clothianidin results in increased expression of DNAJC21 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:59,419,507...59,446,746
Ensembl chr 2:59,419,510...59,446,752
|
|
G |
Dnajc28 |
DnaJ heat shock protein family (Hsp40) member C28 |
decreases expression |
ISO |
clothianidin results in decreased expression of DNAJC28 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:30,855,566...30,858,386
Ensembl chr11:30,853,526...30,858,441
|
|
G |
Dnajc5g |
DnaJ heat shock protein family (Hsp40) member C5 gamma |
increases expression |
ISO |
clothianidin results in increased expression of DNAJC5G mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152
|
|
G |
Dnase1l2 |
deoxyribonuclease 1 like 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of DNASE1L2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,471,479...13,473,763
|
|
G |
Dnhd1 |
dynein heavy chain domain 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of DNHD1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:159,990,785...160,077,990
Ensembl chr 1:159,990,438...160,074,858
|
|
G |
Dok5 |
docking protein 5 |
decreases expression |
ISO |
clothianidin results in decreased expression of DOK5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:159,515,886...159,652,811
Ensembl chr 3:159,515,893...159,652,810
|
|
G |
Dus3l |
dihydrouridine synthase 3-like |
increases expression |
ISO |
clothianidin results in increased expression of DUS3L mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:1,593,491...1,598,663
Ensembl chr 9:1,594,123...1,598,655
|
|
G |
Dusp15 |
dual specificity phosphatase 15 |
increases expression |
ISO |
clothianidin results in increased expression of DUSP15 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
decreases expression |
ISO |
clothianidin results in decreased expression of DUSP16 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
|
|
G |
Eaf2 |
ELL associated factor 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of EAF2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
|
|
G |
Ece2 |
endothelin-converting enzyme 2 |
increases expression |
ISO |
clothianidin results in increased expression of ECE2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:80,259,130...80,278,446
Ensembl chr11:80,263,162...80,278,428
|
|
G |
Efcab12 |
EF-hand calcium binding domain 12 |
decreases expression |
ISO |
clothianidin results in decreased expression of EFCAB12 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 4:148,869,381...148,892,922
Ensembl chr 4:148,869,387...148,890,560
|
|
G |
Efs |
embryonal Fyn-associated substrate |
decreases expression |
ISO |
clothianidin results in decreased expression of EFS mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
|
|
G |
Eif3f |
eukaryotic translation initiation factor 3, subunit F |
decreases expression |
ISO |
clothianidin results in decreased expression of EIF3F mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:162,934,220...162,943,204
Ensembl chr 1:162,934,212...162,943,204
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
increases expression |
ISO |
clothianidin results in increased expression of ELF1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
|
|
G |
Elmod1 |
ELMO domain containing 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of ELMOD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
|
|
G |
Eln |
elastin |
multiple interactions decreases expression |
EXP |
[enilconazole co-treated with clothianidin] results in decreased expression of ELN mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of ELN mRNA clothianidin results in decreased expression of ELN mRNA |
CTD |
PMID:33426623 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
increases expression |
ISO |
clothianidin results in increased expression of ENOX1 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Enpp4 |
ectonucleotide pyrophosphatase/phosphodiesterase 4 |
increases expression |
ISO |
clothianidin results in increased expression of ENPP4 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 9:16,888,923...16,898,860
Ensembl chr 9:16,887,739...16,898,860
|
|
G |
Epdr1 |
ependymin related 1 |
increases expression |
ISO |
clothianidin results in increased expression of EPDR1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr17:45,333,932...45,358,597
Ensembl chr17:45,333,956...45,358,594
|
|
G |
Epn3 |
epsin 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of EPN3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
|
|
G |
Eps8 |
EGFR pathway substrate 8, signaling adaptor |
increases expression |
ISO |
clothianidin results in increased expression of EPS8 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
increases expression |
ISO |
clothianidin results in increased expression of ERBB3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment 1 |
increases expression |
ISO |
clothianidin results in increased expression of ERGIC1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
|
|
G |
Exoc4 |
exocyst complex component 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of EXOC4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:61,807,706...62,584,316
Ensembl chr 4:61,807,761...62,585,723
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
decreases expression |
ISO |
clothianidin results in decreased expression of EZH2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
ISO |
clothianidin results in decreased expression of F2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fam110c |
family with sequence similarity 110, member C |
increases expression |
ISO |
clothianidin results in increased expression of FAM110C mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:47,638,466...47,644,723
Ensembl chr 6:47,638,276...47,644,634
|
|
G |
Fam131a |
family with sequence similarity 131, member A |
decreases expression |
ISO |
clothianidin results in decreased expression of FAM131A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:80,211,577...80,221,527
Ensembl chr11:80,211,745...80,221,511
|
|
G |
Fam151b |
family with sequence similarity 151, member B |
decreases expression |
ISO |
clothianidin results in decreased expression of FAM151B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:23,674,317...23,710,420
Ensembl chr 2:23,674,318...23,710,403
|
|
G |
Fam169a |
family with sequence similarity 169, member A |
increases expression |
ISO |
clothianidin results in increased expression of FAM169A mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 2:28,384,162...28,441,361
Ensembl chr 2:28,383,784...28,438,910
|
|
G |
Fam229a |
family with sequence similarity 229, member A |
decreases expression |
ISO |
clothianidin results in decreased expression of FAM229A mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 5:141,829,716...141,830,705
Ensembl chr 5:141,828,664...141,830,705
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
clothianidin results in increased expression of FASLG mRNA |
CTD |
PMID:35264496 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxo33 |
F-box protein 33 |
decreases expression |
ISO |
clothianidin results in decreased expression of FBXO33 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
|
|
G |
Fer1l4 |
fer-1-like family member 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of FER1L4 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:144,536,099...144,571,634
Ensembl chr 3:144,536,099...144,571,634
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
increases expression |
ISO |
clothianidin results in increased expression of FGFR1 mRNA |
CTD |
PMID:36858607 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
increases expression |
ISO |
clothianidin results in increased expression of FHIT mRNA |
CTD |
PMID:35690182 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Filip1 |
filamin A interacting protein 1 |
increases expression |
ISO |
clothianidin results in increased expression of FILIP1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
|
|
G |
Fitm1 |
fat storage-inducing transmembrane protein 1 |
increases expression |
ISO |
clothianidin results in increased expression of FITM1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:29,064,746...29,066,015
Ensembl chr15:29,064,707...29,066,015
|
|
G |
Folr2 |
folate receptor beta |
increases expression |
ISO |
clothianidin results in increased expression of FOLR2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
clothianidin results in increased expression of FOSL1 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
ISO |
clothianidin results in increased expression of FOXO1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo4 |
forkhead box O4 |
decreases expression |
ISO |
clothianidin results in decreased expression of FOXO4 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Fyb1 |
FYN binding protein 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of FYB1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
|
|
G |
Gabrg1 |
gamma-aminobutyric acid type A receptor subunit gamma 1 |
increases expression |
ISO |
clothianidin results in increased expression of GABRG1 mRNA |
CTD |
PMID:35264496 |
|
NCBI chr14:37,396,217...37,469,606
Ensembl chr14:37,396,294...37,635,956
|
|
G |
Gabrp |
gamma-aminobutyric acid type A receptor subunit pi |
decreases expression |
ISO |
clothianidin results in decreased expression of GABRP mRNA |
CTD |
PMID:35264496 |
|
NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516
|
|
G |
Gask1a |
golgi associated kinase 1A |
increases expression |
ISO |
clothianidin results in increased expression of FAM198A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:121,610,779...121,643,742
Ensembl chr 8:121,610,787...121,642,942
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
clothianidin results in increased expression of GDF15 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Ghrhr |
growth hormone releasing hormone receptor |
increases expression |
ISO |
clothianidin results in increased expression of GHRHR mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of GLI1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gngt1 |
G protein subunit gamma transducin 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of GNGT1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:32,006,267...32,009,252
Ensembl chr 4:32,006,267...32,009,252
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
ISO |
clothianidin results in decreased expression of GNMT mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gpc6 |
glypican 6 |
increases expression |
ISO |
clothianidin results in increased expression of GPC6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:94,030,218...95,027,883
Ensembl chr15:94,029,884...95,024,006
|
|
G |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
increases expression |
ISO |
clothianidin results in increased expression of GPCPD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:119,787,682...119,832,517
|
|
G |
Gpihbp1 |
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
increases expression |
ISO |
clothianidin results in increased expression of GPIHBP1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702
|
|
G |
Gpr15lg |
G protein-coupled receptor 15 ligand |
decreases expression |
ISO |
clothianidin results in decreased expression of GPR15LG mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:12,868,270...12,875,876
Ensembl chr16:12,868,270...12,875,876
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of GPX4 protein |
CTD |
PMID:25960033 PMID:33563863 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gramd1c |
GRAM domain containing 1C |
decreases expression |
ISO |
clothianidin results in decreased expression of GRAMD1C mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:56,633,229...56,718,570
Ensembl chr11:56,633,227...56,718,570
|
|
G |
Gramd2a |
GRAM domain containing 2A |
decreases expression |
ISO |
clothianidin results in decreased expression of GRAMD2A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:60,079,744...60,117,788
Ensembl chr 8:60,080,338...60,115,842
|
|
G |
Gskip |
GSK3B interacting protein |
increases expression |
ISO |
clothianidin results in increased expression of GSKIP mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 6:124,586,087...124,609,106
Ensembl chr 6:124,586,070...124,609,100
|
|
G |
Gtf3c5 |
general transcription factor IIIC subunit 5 |
increases expression |
ISO |
clothianidin results in increased expression of GTF3C5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:11,893,867...11,914,187
Ensembl chr 3:11,893,875...11,914,180
|
|
G |
Gtsf1l |
gametocyte specific factor 1-like |
increases expression |
ISO |
clothianidin results in increased expression of GTSF1L mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:151,736,020...151,738,715
Ensembl chr 3:151,735,997...151,736,863
|
|
G |
Gypc |
glycophorin C |
increases expression |
ISO |
clothianidin results in increased expression of GYPC mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:24,160,738...24,193,408
Ensembl chr18:24,160,739...24,193,204
|
|
G |
H1f7 |
H1.7 linker histone |
increases expression |
ISO |
clothianidin results in increased expression of H1-7 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:129,408,521...129,409,888
Ensembl chr 7:129,408,359...129,409,930
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
increases expression |
ISO |
clothianidin results in increased expression of HACD2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
clothianidin results in increased expression of HCK mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
increases expression |
ISO |
clothianidin results in increased expression of HECTD2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:234,274,967...234,345,598
Ensembl chr 1:234,275,705...234,343,487
|
|
G |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of HECW2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:55,359,462...55,753,106
Ensembl chr 9:55,365,203...55,580,327
|
|
G |
Hgf |
hepatocyte growth factor |
decreases expression |
ISO |
clothianidin results in decreased expression of HGF mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hid1 |
HID1 domain containing |
decreases expression |
ISO |
clothianidin results in decreased expression of HID1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:100,589,555...100,610,050
Ensembl chr10:100,589,555...100,610,041
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
increases expression |
ISO |
clothianidin results in increased expression of HMBS mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Hnf1b |
HNF1 homeobox B |
increases expression |
ISO |
clothianidin results in increased expression of HNF1B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression |
ISO |
clothianidin results in increased expression of HNF4A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
decreases expression |
ISO |
clothianidin results in decreased expression of HNRNPK mRNA |
CTD |
PMID:31626844 |
|
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Ift70b |
intraflagellar transport 70B |
decreases expression |
ISO |
clothianidin results in decreased expression of IFT70B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:60,855,809...60,858,380
Ensembl chr 3:60,855,575...60,858,389
|
|
G |
Il17re |
interleukin 17 receptor E |
decreases expression |
ISO |
clothianidin results in decreased expression of IL17RE mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 4:146,604,547...146,618,206
Ensembl chr 4:146,605,526...146,618,206
|
|
G |
Il18bp |
interleukin 18 binding protein |
decreases expression |
ISO |
clothianidin results in decreased expression of IL18BP mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
increases expression |
ISO |
clothianidin results in increased expression of IL2RG mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
|
|
G |
Immp1l |
inner mitochondrial membrane peptidase subunit 1 |
increases expression |
ISO |
clothianidin results in increased expression of IMMP1L mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:92,385,329...92,449,559
Ensembl chr 3:92,385,379...92,452,313
|
|
G |
Inhba |
inhibin subunit beta A |
increases expression |
ISO |
clothianidin results in increased expression of INHBA mRNA |
CTD |
PMID:33563863 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Insyn2b |
inhibitory synaptic factor family member 2B |
decreases expression |
ISO |
clothianidin results in decreased expression of INSYN2B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:18,916,721...19,023,859
Ensembl chr10:19,003,131...19,022,139
|
|
G |
Irx5 |
iroquois homeobox 5 |
decreases expression |
ISO |
clothianidin results in decreased expression of IRX5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
|
|
G |
Itsn1 |
intersectin 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of ITSN1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
|
|
G |
Jak2 |
Janus kinase 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of JAK2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kat6b |
lysine acetyltransferase 6B |
decreases expression |
ISO |
clothianidin results in decreased expression of KAT6B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:2,638,885...2,811,977
Ensembl chr15:2,639,200...2,812,316
|
|
G |
Kcnc4 |
potassium voltage-gated channel subfamily C member 4 |
increases expression |
ISO |
clothianidin results in increased expression of KCNC4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:195,063,967...195,100,244
Ensembl chr 2:195,071,769...195,099,233
|
|
G |
Kcnd3 |
potassium voltage-gated channel subfamily D member 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of KCND3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
|
|
G |
Kcnk1 |
potassium two pore domain channel subfamily K member 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of KCNK1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of KCNMA1 mRNA |
CTD |
PMID:31626844 PMID:35690182 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Kif7 |
kinesin family member 7 |
increases expression |
ISO |
clothianidin results in increased expression of KIF7 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:133,639,487...133,658,539
Ensembl chr 1:133,640,065...133,658,576
|
|
G |
Kifc3 |
kinesin family member C3 |
increases expression |
ISO |
clothianidin results in increased expression of KIFC3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
increases expression |
ISO |
clothianidin results in increased expression of KIT mRNA |
CTD |
PMID:31626844 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Klhdc9 |
kelch domain containing 9 |
decreases expression |
ISO |
clothianidin results in decreased expression of KLHDC9 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr13:83,790,390...83,794,080
Ensembl chr13:83,790,269...83,793,354
|
|
G |
Kpna6 |
karyopherin subunit alpha 6 |
increases expression |
ISO |
clothianidin results in increased expression of KPNA6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:141,988,111...142,021,483
Ensembl chr 5:141,991,568...142,021,120
|
|
G |
Krt28 |
keratin 28 |
increases expression |
ISO |
clothianidin results in increased expression of KRT28 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:84,318,352...84,328,693
Ensembl chr10:84,318,543...84,328,643
|
|
G |
Ksr1 |
kinase suppressor of ras 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of KSR1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:63,961,771...64,098,076
Ensembl chr10:63,961,759...64,098,076
|
|
G |
Ky |
kyphoscoliosis peptidase |
multiple interactions decreases expression |
EXP |
[enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA clothianidin results in decreased expression of KY mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 8:103,086,959...103,126,305
Ensembl chr 8:103,086,630...103,126,024
|
|
G |
L3mbtl1 |
L3MBTL histone methyl-lysine binding protein 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of L3MBTL1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:151,597,903...151,633,657
Ensembl chr 3:151,602,980...151,631,233
|
|
G |
Lgals12 |
galectin 12 |
increases expression |
ISO |
clothianidin results in increased expression of LGALS12 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:204,832,065...204,842,759
Ensembl chr 1:204,832,065...204,842,759
|
|
G |
Lgi4 |
leucine-rich repeat LGI family, member 4 |
increases expression |
ISO |
clothianidin results in increased expression of LGI4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:86,294,539...86,305,909
Ensembl chr 1:86,295,074...86,304,874
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
decreases expression |
ISO |
clothianidin results in decreased expression of LIF mRNA |
CTD |
PMID:35690182 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lim2 |
lens intrinsic membrane protein 2 |
increases expression |
ISO |
clothianidin results in increased expression of LIM2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:93,837,597...93,843,769
Ensembl chr 1:93,837,597...93,843,769
|
|
G |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
increases expression |
ISO |
clothianidin results in increased expression of LONRF1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:55,984,572...56,015,156
Ensembl chr16:55,984,463...56,015,156
|
|
G |
Lox |
lysyl oxidase |
increases expression |
ISO |
clothianidin results in increased expression of LOX mRNA |
CTD |
PMID:29044138 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of LPAR1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
|
|
G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
increases expression |
ISO |
clothianidin results in increased expression of LRIG1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:127,130,898...127,231,513
|
|
G |
Lrmda |
leucine rich melanocyte differentiation associated |
decreases expression |
ISO |
clothianidin results in decreased expression of LRMDA mRNA |
CTD |
PMID:35690182 |
|
NCBI chr15:1,223,098...2,284,764
Ensembl chr15:1,225,710...2,284,749
|
|
G |
Lrrc74b |
leucine rich repeat containing 74B |
decreases expression |
ISO |
clothianidin results in decreased expression of LRRC74B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:83,450,588...83,468,906
Ensembl chr11:83,450,624...83,468,922
|
|
G |
Luzp2 |
leucine zipper protein 2 |
increases expression |
ISO |
clothianidin results in increased expression of LUZP2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:105,597,291...105,983,605
Ensembl chr 1:105,597,307...105,981,183
|
|
G |
Lysmd2 |
LysM domain containing 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of LYSMD2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:76,378,984...76,394,396
Ensembl chr 8:76,379,219...76,394,654
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
clothianidin results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:31626844 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
clothianidin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:31626844 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
increases expression |
ISO |
clothianidin results in increased expression of MCHR1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
|
|
G |
Megf11 |
multiple EGF-like-domains 11 |
multiple interactions decreases expression |
EXP |
[enilconazole co-treated with clothianidin] results in decreased expression of MEGF11 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of MEGF11 mRNA clothianidin results in decreased expression of MEGF11 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 8:64,892,312...65,218,984
Ensembl chr 8:64,892,387...65,216,061
|
|
G |
Meioc |
meiosis specific with coiled-coil domain |
increases expression |
ISO |
clothianidin results in increased expression of MEIOC mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:87,628,807...87,646,485
Ensembl chr10:87,628,875...87,646,752
|
|
G |
Mettl16 |
methyltransferase 16, RNA N6-adenosine |
increases expression |
ISO |
clothianidin results in increased expression of METTL16 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:59,640,915...59,697,291
Ensembl chr10:59,640,972...59,687,061
|
|
G |
Mical1 |
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
increases expression |
ISO |
clothianidin results in increased expression of MICAL1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:44,974,137...44,986,089
Ensembl chr20:44,974,138...44,986,089
|
|
G |
Micall2 |
MICAL-like 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of MICALL2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr12:14,899,188...14,927,949
Ensembl chr12:14,899,157...14,927,946
|
|
G |
Mlana |
melan-A |
increases expression |
ISO |
clothianidin results in increased expression of MLANA mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343
|
|
G |
Mme |
membrane metallo-endopeptidase |
multiple interactions increases expression |
EXP |
[enilconazole co-treated with clothianidin] results in increased expression of MME mRNA; [thiacloprid co-treated with clothianidin] results in increased expression of MME mRNA clothianidin results in increased expression of MME mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
increases expression |
ISO |
clothianidin results in increased expression of MMP10 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
decreases expression |
ISO |
clothianidin results in decreased expression of MS4A2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
|
|
G |
Mss51 |
MSS51 mitochondrial translational activator |
decreases expression |
ISO |
clothianidin results in decreased expression of MSS51 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr15:3,805,240...3,819,385
Ensembl chr15:3,807,516...3,819,385
|
|
G |
Mtg1 |
mitochondrial ribosome-associated GTPase 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of MTG1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:194,931,543...194,944,278
Ensembl chr 1:194,931,531...194,944,277
|
|
G |
Myl11 |
myosin light chain 11 |
decreases expression |
ISO |
clothianidin results in decreased expression of MYL11 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:181,829,703...181,832,546
Ensembl chr 1:181,829,743...181,832,545
|
|
G |
Myl4 |
myosin, light chain 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of MYL4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myl6 |
myosin light chain 6 |
decreases expression |
ISO |
clothianidin results in decreased expression of MYL6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
|
|
G |
Myo3b |
myosin IIIB |
increases expression |
ISO |
clothianidin results in increased expression of MYO3B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:54,820,225...55,228,518
Ensembl chr 3:54,820,251...55,227,373
|
|
G |
Myorg |
myogenesis regulating glycosidase |
increases expression |
ISO |
clothianidin results in increased expression of MYORG mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 5:56,654,257...56,664,467
Ensembl chr 5:56,648,643...56,664,440
|
|
G |
Myt1l |
myelin transcription factor 1-like |
increases expression |
ISO |
clothianidin results in increased expression of MYT1L mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:46,164,742...46,564,234
Ensembl chr 6:46,428,150...46,561,671
|
|
G |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
increases expression |
ISO |
clothianidin results in increased expression of N4BP2L1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
|
|
G |
Nadsyn1 |
NAD synthetase 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of NADSYN1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:198,981,559...199,009,853
Ensembl chr 1:198,981,604...199,009,869
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
decreases expression |
ISO |
clothianidin results in decreased expression of NASP mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression |
ISO |
clothianidin results in increased expression of NCF2 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ndufa10 |
NADH:ubiquinone oxidoreductase subunit A10 |
increases expression |
ISO |
clothianidin results in increased expression of NDUFA10 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:93,007,034...93,041,825
Ensembl chr 9:93,007,042...93,042,560
|
|
G |
Nectin4 |
nectin cell adhesion molecule 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of NECTIN4 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr13:83,802,589...83,821,711
Ensembl chr13:83,803,184...83,821,709
|
|
G |
Neurod4 |
neuronal differentiation 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of NEUROD4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:7,090,048...7,102,018
Ensembl chr 7:7,090,045...7,102,030
|
|
G |
Ngef |
neuronal guanine nucleotide exchange factor |
increases expression |
ISO |
clothianidin results in increased expression of NGEF mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914
|
|
G |
Ngfr |
nerve growth factor receptor |
increases expression |
ISO |
clothianidin results in increased expression of NGFR mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Ninl |
ninein-like |
decreases expression |
ISO |
clothianidin results in decreased expression of NINL mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 3:139,748,353...139,814,683
Ensembl chr 3:139,748,355...139,814,622
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
clothianidin results in increased expression of NOS2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression multiple interactions |
ISO |
clothianidin results in decreased expression of NR0B2 mRNA [clothianidin co-treated with enilconazole] results in decreased expression of NR0B2 mRNA |
CTD |
PMID:32201337 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Ntn4 |
netrin 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of NTN4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:28,186,611...28,300,390
Ensembl chr 7:28,186,611...28,300,390
|
|
G |
Nts |
neurotensin |
decreases expression |
ISO |
clothianidin results in decreased expression of NTS mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Nxnl2 |
nucleoredoxin-like 2 |
increases expression |
ISO |
clothianidin results in increased expression of NXNL2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr17:14,031,151...14,035,897
Ensembl chr17:14,031,153...14,036,189
|
|
G |
Nxph2 |
neurexophilin 2 |
increases expression |
ISO |
clothianidin results in increased expression of NXPH2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:5,986,175...5,988,525
Ensembl chr 3:5,756,621...5,987,008
|
|
G |
Ocrl |
OCRL, inositol polyphosphate-5-phosphatase |
decreases expression |
ISO |
clothianidin results in decreased expression of OCRL mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:127,089,508...127,140,362
Ensembl chr X:127,089,590...127,140,362
|
|
G |
Olr59 |
olfactory receptor 59 |
increases expression |
ISO |
clothianidin results in increased expression of OR51E2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Otud6b |
OTU deubiquitinase 6B |
increases expression |
ISO |
clothianidin results in increased expression of OTUD6B mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 5:28,181,992...28,214,486
Ensembl chr 5:28,023,594...28,214,334
|
|
G |
Padi4 |
peptidyl arginine deiminase 4 |
increases expression |
ISO |
clothianidin results in increased expression of PADI4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362
|
|
G |
Pak5 |
p21 (RAC1) activated kinase 5 |
decreases expression |
ISO |
clothianidin results in decreased expression of PAK5 mRNA |
CTD |
PMID:31626844 PMID:35690182 |
|
NCBI chr 3:123,395,678...123,703,967
Ensembl chr 3:123,396,497...123,703,930
|
|
G |
Paqr8 |
progestin and adipoQ receptor family member 8 |
decreases expression |
ISO |
clothianidin results in decreased expression of PAQR8 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 9:23,312,521...23,362,175
Ensembl chr 9:23,312,585...23,362,340
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of PBLD mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
|
|
G |
Pcca |
propionyl-CoA carboxylase subunit alpha |
decreases expression |
ISO |
clothianidin results in decreased expression of PCCA mRNA |
CTD |
PMID:32201337 |
|
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of PCSK1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
|
|
G |
Pde10a |
phosphodiesterase 10A |
decreases expression |
ISO |
clothianidin results in decreased expression of PDE10A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:51,765,743...52,218,086
Ensembl chr 1:51,770,132...52,216,563
|
|
G |
Pde1c |
phosphodiesterase 1C |
increases expression |
ISO |
clothianidin results in increased expression of PDE1C mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:85,300,858...85,863,219
|
|
G |
Pde4dip |
phosphodiesterase 4D interacting protein |
increases expression |
ISO |
clothianidin results in increased expression of PDE4DIP mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
|
|
G |
Pdzd7 |
PDZ domain containing 7 |
decreases expression |
ISO |
clothianidin results in decreased expression of PDZD7 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:243,888,295...243,907,778
Ensembl chr 1:243,888,281...243,906,839
|
|
G |
Peli2 |
pellino E3 ubiquitin protein ligase family member 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of PELI2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:21,393,262...21,537,737
Ensembl chr15:21,393,262...21,535,106
|
|
G |
Pgap6 |
post-GPI attachment to proteins 6 |
decreases expression |
ISO |
clothianidin results in decreased expression of PGAP6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:15,138,918...15,148,431
Ensembl chr10:15,138,959...15,148,431
|
|
G |
Pgr |
progesterone receptor |
increases expression |
ISO |
clothianidin results in increased expression of PGR mRNA |
CTD |
PMID:33563863 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
increases expression |
ISO |
clothianidin results in increased expression of FAM109B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:113,855,437...113,861,910
Ensembl chr 7:113,857,249...113,861,871
|
|
G |
Pik3c2b |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
decreases expression |
ISO |
clothianidin results in decreased expression of PIK3C2B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr13:44,494,673...44,555,663
Ensembl chr13:44,495,050...44,555,612
|
|
G |
Pip5k1c |
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma |
decreases expression |
ISO |
clothianidin results in decreased expression of PIP5K1C mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:8,397,406...8,426,030
Ensembl chr 7:8,397,406...8,425,988
|
|
G |
Pip5kl1 |
phosphatidylinositol-4-phosphate 5-kinase-like 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of PIP5KL1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:15,860,493...15,869,264
Ensembl chr 3:15,855,946...15,869,165
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
increases expression |
ISO |
clothianidin results in increased expression of PLA2G2A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Plbd1 |
phospholipase B domain containing 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of PLBD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
|
|
G |
Plcd1 |
phospholipase C, delta 1 |
increases expression |
ISO |
clothianidin results in increased expression of PLCD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
|
|
G |
Plcd3 |
phospholipase C, delta 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of PLCD3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:88,026,707...88,048,080
Ensembl chr10:88,026,740...88,048,296
|
|
G |
Plcl1 |
phospholipase C-like 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of PLCL1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:56,901,573...57,238,782
Ensembl chr 9:56,901,534...57,238,782
|
|
G |
Pllp |
plasmolipin |
increases expression |
ISO |
clothianidin results in increased expression of PLLP mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:10,315,104...10,335,892
Ensembl chr19:10,315,104...10,335,892
|
|
G |
Pnpla1 |
patatin-like phospholipase domain containing 1 |
increases expression |
ISO |
clothianidin results in increased expression of PNPLA1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,917,931...6,952,375
|
|
G |
Polr2m |
RNA polymerase II subunit M |
decreases expression |
ISO |
clothianidin results in decreased expression of POLR2M mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:72,131,992...72,139,423
Ensembl chr 8:72,131,530...72,243,036
|
|
G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
increases expression |
ISO |
clothianidin results in increased expression of PPP1R3C mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
|
|
G |
Ppp3cc |
protein phosphatase 3 catalytic subunit gamma |
increases expression |
ISO |
clothianidin results in increased expression of PPP3CC mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832
|
|
G |
Prg3 |
proteoglycan 3, pro eosinophil major basic protein 2 |
increases expression |
ISO |
clothianidin results in increased expression of PRG3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:70,071,970...70,078,103
Ensembl chr 3:70,072,497...70,078,102
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
decreases expression |
ISO |
clothianidin results in decreased expression of PARK2 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Prlr |
prolactin receptor |
decreases expression |
ISO |
clothianidin results in decreased expression of PRLR mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Prnd |
prion like protein doppel |
increases expression |
ISO |
clothianidin results in increased expression of PRND mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:119,213,462...119,218,742
Ensembl chr 3:119,213,429...119,218,745
|
|
G |
Prodh2 |
proline dehydrogenase 2 |
increases expression |
ISO |
clothianidin results in increased expression of PRODH2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
|
|
G |
Prr5l |
proline rich 5 like |
increases expression |
ISO |
clothianidin results in increased expression of PRR5L mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:88,003,617...88,082,763
|
|
G |
Prxl2b |
peroxiredoxin like 2B |
decreases expression |
ISO |
clothianidin results in decreased expression of PRXL2B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:165,462,610...165,465,213
|
|
G |
Psen1 |
presenilin 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of PSEN1 mRNA |
CTD |
PMID:35264496 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Psmc6 |
proteasome 26S subunit, ATPase 6 |
decreases expression |
ISO |
clothianidin results in decreased expression of PSMC6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
|
|
G |
Ptgfr |
prostaglandin F receptor |
decreases expression |
ISO |
clothianidin results in decreased expression of PTGFR mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:240,731,185...240,766,674
Ensembl chr 2:240,733,375...240,765,650
|
|
G |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
increases expression |
ISO |
clothianidin results in increased expression of PTPN3 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 5:71,908,520...72,027,323
Ensembl chr 5:71,911,135...72,065,443
|
|
G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
decreases expression |
ISO |
clothianidin results in decreased expression of PTPRB mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
decreases expression |
ISO |
clothianidin results in decreased expression of PTPRO mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
|
|
G |
Qpct |
glutaminyl-peptide cyclotransferase |
increases expression |
ISO |
clothianidin results in increased expression of QPCT mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:15,964,656...15,996,730
Ensembl chr 6:15,964,657...15,996,711
|
|
G |
Rag1 |
recombination activating 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of RAG1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:87,917,061...87,928,158
Ensembl chr 3:87,917,004...87,928,291
|
|
G |
Rapgefl1 |
Rap guanine nucleotide exchange factor like 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of RAPGEFL1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:83,793,711...83,810,373
Ensembl chr10:83,793,694...83,810,371
|
|
G |
Rbm26 |
RNA binding motif protein 26 |
decreases expression |
ISO |
clothianidin results in decreased expression of RBM26 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118
|
|
G |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of RBMS1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:45,195,828...45,420,406
Ensembl chr 3:45,197,972...45,420,376
|
|
G |
Reg3g |
regenerating family member 3 gamma |
increases expression |
ISO |
clothianidin results in increased expression of REG3G mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:110,922,805...110,927,803
Ensembl chr 4:110,924,168...110,926,723
|
|
G |
Rfesd |
Rieske (Fe-S) domain containing |
decreases expression |
ISO |
clothianidin results in decreased expression of RFESD mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:5,495,067...5,521,095
Ensembl chr 2:5,505,756...5,522,449
|
|
G |
Riiad1 |
regulatory subunit of type II PKA R-subunit domain containing 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of RIIAD1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:182,099,924...182,110,544
Ensembl chr 2:182,101,795...182,110,319
|
|
G |
Rnd1 |
Rho family GTPase 1 |
increases expression |
ISO |
clothianidin results in increased expression of RND1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
|
|
G |
Rp1l1 |
RP1 like 1 |
increases expression |
ISO |
clothianidin results in increased expression of RP1L1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr15:38,259,907...38,271,269
Ensembl chr15:38,259,928...38,270,316
|
|
G |
Rps29 |
ribosomal protein S29 |
increases expression |
ISO |
clothianidin results in increased expression of RPS29 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:87,635,229...87,636,627
Ensembl chr 6:87,635,230...87,636,636
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
increases expression |
ISO |
clothianidin results in increased expression of RRAD mRNA |
CTD |
PMID:35690182 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
increases expression |
ISO |
clothianidin results in increased expression of HLA-DQB1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
S100a5 |
S100 calcium binding protein A5 |
decreases expression |
ISO |
clothianidin results in decreased expression of S100A5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:176,095,332...176,099,546
Ensembl chr 2:176,097,539...176,099,546
|
|
G |
Sash3 |
SAM and SH3 domain containing 3 |
increases expression |
ISO |
clothianidin results in increased expression of SASH3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519
|
|
G |
Scn7a |
sodium voltage-gated channel alpha subunit 7 |
decreases expression |
ISO |
clothianidin results in decreased expression of SCN7A mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 3:51,335,841...51,438,308
Ensembl chr 3:51,335,841...51,438,256
|
|
G |
Scnn1b |
sodium channel epithelial 1 subunit beta |
increases expression |
ISO |
clothianidin results in increased expression of SCNN1B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:176,430,063...176,484,451
Ensembl chr 1:176,430,103...176,484,451
|
|
G |
Sema3f |
semaphorin 3F |
decreases expression |
ISO |
clothianidin results in decreased expression of SEMA3F mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:108,357,629...108,386,569
Ensembl chr 8:108,357,629...108,387,083
|
|
G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of SERP1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:142,757,270...142,761,116
|
|
G |
Serpina3n |
serpin family A member 3N |
decreases expression |
ISO |
clothianidin results in decreased expression of SERPINA3N mRNA |
CTD |
PMID:35264496 |
|
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Serpinc1 |
serpin family C member 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of SERPINC1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of SERPINE1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sgcd |
sarcoglycan, delta |
increases expression |
ISO |
clothianidin results in increased expression of SGCD mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:31,346,480...32,328,364
Ensembl chr10:31,280,511...31,724,840
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of SGK2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
increases expression |
ISO |
clothianidin results in increased expression of SH3TC1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr14:75,005,691...75,050,001
Ensembl chr14:75,016,875...75,049,995
|
|
G |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
increases expression |
ISO |
clothianidin results in increased expression of SIPA1L2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr19:53,389,792...53,540,466
Ensembl chr19:53,389,805...53,540,428
|
|
G |
Slc14a1 |
solute carrier family 14 member 1 (Kidd blood group) |
decreases expression |
ISO |
clothianidin results in decreased expression of SLC14A1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
|
|
G |
Slc17a7 |
solute carrier family 17 member 7 |
decreases expression |
ISO |
clothianidin results in decreased expression of SLC17A7 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases activity |
ISO |
clothianidin results in decreased activity of SLC22A2 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity |
ISO |
clothianidin results in decreased activity of SLC22A6 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases activity |
ISO |
clothianidin results in decreased activity of SLC22A8 protein |
CTD |
PMID:31364238 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc28a1 |
solute carrier family 28 member 1 |
increases expression |
ISO |
clothianidin results in increased expression of SLC28A1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
|
|
G |
Slc38a9 |
solute carrier family 38, member 9 |
decreases expression |
ISO |
clothianidin results in decreased expression of SLC38A9 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:44,291,637...44,374,897
Ensembl chr 2:44,291,989...44,368,955
|
|
G |
Slc45a2 |
solute carrier family 45, member 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of SLC45A2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:59,963,599...59,996,408
Ensembl chr 2:59,963,706...59,996,317
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
decreases activity |
ISO |
clothianidin results in decreased activity of SLC47A2 protein |
CTD |
PMID:31364238 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Slc48a1 |
solute carrier family 48 member 1 |
increases expression |
ISO |
clothianidin results in increased expression of SLC48A1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:128,915,136...128,923,929
Ensembl chr 7:128,915,195...128,923,024
|
|
G |
Slc6a1 |
solute carrier family 6 member 1 |
decreases expression multiple interactions |
EXP |
clothianidin results in decreased expression of SLC6A1 mRNA [enilconazole co-treated with clothianidin] results in decreased expression of SLC6A1 mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of SLC6A1 mRNA |
CTD |
PMID:33426623 |
|
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
|
|
G |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
increases expression |
ISO |
clothianidin results in increased expression of SLCO1C1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
|
|
G |
Smpd3 |
sphingomyelin phosphodiesterase 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of SMPD3 mRNA |
CTD |
PMID:35690182 |
|
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
increases expression |
ISO |
clothianidin results in increased expression of SORBS1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
|
|
G |
Spata3 |
spermatogenesis associated 3 |
increases expression |
ISO |
clothianidin results in increased expression of SPATA3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:86,660,352...86,672,272
Ensembl chr 9:86,659,784...86,672,272
|
|
G |
Spire2 |
spire-type actin nucleation factor 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of SPIRE2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr19:51,373,368...51,411,920
Ensembl chr19:51,373,228...51,411,920
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
increases expression |
ISO |
clothianidin results in increased expression of SRD5A2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Sspo |
SCO-spondin |
decreases expression |
ISO |
clothianidin results in decreased expression of SSPOP mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 4:77,394,915...77,450,526
Ensembl chr 4:77,397,059...77,450,412
|
|
G |
Stac2 |
SH3 and cysteine rich domain 2 |
increases expression |
ISO |
clothianidin results in increased expression of STAC2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:83,032,418...83,048,260
Ensembl chr10:83,032,417...83,048,260
|
|
G |
Steap2 |
STEAP2 metalloreductase |
increases expression |
ISO |
clothianidin results in increased expression of STEAP2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:28,347,769...28,368,177
Ensembl chr 4:28,348,362...28,375,791
|
|
G |
Susd4 |
sushi domain containing 4 |
increases expression |
ISO |
clothianidin results in increased expression of SUSD4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr13:94,455,180...94,577,773
Ensembl chr13:94,455,165...94,577,750
|
|
G |
Sycp2 |
synaptonemal complex protein 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of SYCP2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:165,436,331...165,498,789
|
|
G |
Synpo |
synaptopodin |
decreases expression |
ISO |
clothianidin results in decreased expression of SYNPO mRNA |
CTD |
PMID:29044138 |
|
NCBI chr18:54,048,299...54,106,388
Ensembl chr18:54,026,152...54,102,126
|
|
G |
Tacr1 |
tachykinin receptor 1 |
increases expression |
ISO |
clothianidin results in increased expression of TACR1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tafa2 |
TAFA chemokine like family member 2 |
decreases expression |
ISO |
clothianidin results in decreased expression of FAM19A2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:58,942,598...59,418,640
Ensembl chr 7:58,942,610...59,417,299
|
|
G |
Tafa5 |
TAFA chemokine like family member 5 |
increases expression |
ISO |
clothianidin results in increased expression of FAM19A5 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:118,613,731...118,835,016
Ensembl chr 7:118,613,889...118,834,353
|
|
G |
Tbx2 |
T-box transcription factor 2 |
increases expression |
ISO |
clothianidin results in increased expression of TBX2 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:70,679,670...70,688,868
Ensembl chr10:70,679,518...70,688,529
|
|
G |
Tcp10b |
t-complex protein 10b |
increases expression |
ISO |
clothianidin results in increased expression of TCP10L2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:52,937,823...52,961,307
Ensembl chr 1:52,937,917...52,961,307
|
|
G |
Tecpr1 |
tectonin beta-propeller repeat containing 1 |
decreases expression |
ISO |
clothianidin results in decreased expression of TECPR1 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr12:10,391,587...10,420,462
Ensembl chr12:10,391,696...10,419,611
|
|
G |
Tef |
TEF transcription factor, PAR bZIP family member |
increases expression |
ISO |
clothianidin results in increased expression of TEF mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:113,317,191...113,341,783
Ensembl chr 7:113,317,283...113,341,783
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
increases expression |
ISO |
clothianidin results in increased expression of TGFBI mRNA |
CTD |
PMID:31626844 |
|
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
|
|
G |
Tgm5 |
transglutaminase 5 |
decreases expression |
ISO |
clothianidin results in decreased expression of TGM5 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:108,008,087...108,044,013
Ensembl chr 3:108,008,143...108,043,976
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
ISO |
clothianidin results in decreased expression of THRSP mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
increases expression |
ISO |
clothianidin results in increased expression of TICAM1 mRNA |
CTD |
PMID:35264496 |
|
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
increases expression |
ISO |
clothianidin results in increased expression of TIFA mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:216,257,926...216,267,635
Ensembl chr 2:216,234,774...216,267,841
|
|
G |
Tlcd4 |
TLC domain containing 4 |
increases expression |
ISO |
clothianidin results in increased expression of TLCD4 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 2:209,284,873...209,360,156
Ensembl chr 2:209,289,732...209,341,353
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
ISO |
clothianidin results in increased expression of TLR2 mRNA |
CTD |
PMID:35264496 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlx3 |
T-cell leukemia, homeobox 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of TLX3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:17,789,706...17,792,207
Ensembl chr10:17,790,053...17,792,207
|
|
G |
Tmem273 |
transmembrane protein 273 |
increases expression |
ISO |
clothianidin results in increased expression of TMEM273 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:8,049,565...8,081,981
Ensembl chr16:8,049,669...8,081,981
|
|
G |
Tmem38a |
transmembrane protein 38a |
decreases expression |
ISO |
clothianidin results in decreased expression of TMEM38A mRNA |
CTD |
PMID:29044138 |
|
NCBI chr16:17,258,160...17,274,204
Ensembl chr16:17,258,164...17,273,415
|
|
G |
Tmem71 |
transmembrane protein 71 |
decreases expression |
ISO |
clothianidin results in decreased expression of TMEM71 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:98,276,975...98,315,858
|
|
G |
Tmt1a |
thiol methyltransferase 1A |
decreases expression |
ISO |
clothianidin results in decreased expression of TMT1A mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
clothianidin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; clothianidin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:29044138 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
decreases expression |
ISO |
clothianidin results in decreased expression of TNFRSF11B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnxb |
tenascin XB |
decreases expression |
ISO |
clothianidin results in decreased expression of TNXB mRNA |
CTD |
PMID:29044138 |
|
|
|
G |
Tpm1 |
tropomyosin 1 |
increases expression |
ISO |
clothianidin results in increased expression of TPM1 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
increases expression |
ISO |
clothianidin results in increased expression of TRAF4 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
decreases expression |
ISO |
clothianidin results in decreased expression of TRAF6 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Trappc4 |
trafficking protein particle complex subunit 4 |
increases expression |
ISO |
clothianidin results in increased expression of TRAPPC4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:44,729,458...44,733,285
Ensembl chr 8:44,725,331...44,733,491
|
|
G |
Trim37 |
tripartite motif-containing 37 |
decreases expression |
ISO |
clothianidin results in decreased expression of TRIM37 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:71,943,384...72,075,563
Ensembl chr10:71,943,375...72,075,558
|
|
G |
Trmt44 |
tRNA methyltransferase 44 |
increases expression |
ISO |
clothianidin results in increased expression of TRMT44 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr14:75,175,331...75,204,291
Ensembl chr14:75,182,029...75,200,147
|
|
G |
Tssk6 |
testis-specific serine kinase 6 |
decreases expression |
ISO |
clothianidin results in decreased expression of TSSK6 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:19,523,626...19,526,074
Ensembl chr16:19,517,334...19,526,090
|
|
G |
Ttc28 |
tetratricopeptide repeat domain 28 |
decreases expression |
ISO |
clothianidin results in decreased expression of TTC28 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr12:45,342,986...45,783,968
Ensembl chr12:45,345,399...45,783,547
|
|
G |
Ttc33 |
tetratricopeptide repeat domain 33 |
decreases expression |
ISO |
clothianidin results in decreased expression of TTC33 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 2:54,279,906...54,326,851
Ensembl chr 2:54,279,997...54,323,871
|
|
G |
Ttc8 |
tetratricopeptide repeat domain 8 |
decreases expression |
ISO |
clothianidin results in decreased expression of TTC8 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 6:118,198,186...118,252,422
Ensembl chr 6:118,198,201...118,252,418
|
|
G |
Tubgcp3 |
tubulin gamma complex component 3 |
increases expression |
ISO |
clothianidin results in increased expression of TUBGCP3 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr16:76,851,859...76,912,499
Ensembl chr16:76,851,810...76,912,499
|
|
G |
Txndc2 |
thioredoxin domain containing 2 |
increases expression |
ISO |
clothianidin results in increased expression of TXNDC2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 9:105,230,575...105,235,131
Ensembl chr 9:105,230,578...105,235,126
|
|
G |
Ubap1l |
ubiquitin associated protein 1-like |
decreases expression increases expression |
ISO |
clothianidin results in decreased expression of UBAP1L mRNA clothianidin results in increased expression of UBAP1L mRNA |
CTD |
PMID:29044138 PMID:31626844 |
|
NCBI chr 8:65,877,488...65,897,593
Ensembl chr 8:65,884,729...65,897,593
|
|
G |
Unc119b |
unc-119 lipid binding chaperone B |
increases expression |
ISO |
clothianidin results in increased expression of UNC119B mRNA |
CTD |
PMID:31626844 |
|
NCBI chr12:41,478,808...41,491,432
Ensembl chr12:41,478,808...41,491,432
|
|
G |
Usp43 |
ubiquitin specific peptidase 43 |
decreases expression |
ISO |
clothianidin results in decreased expression of USP43 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:52,549,200...52,611,168
Ensembl chr10:52,548,963...52,611,533
|
|
G |
Utrn |
utrophin |
decreases expression |
ISO |
clothianidin results in decreased expression of UTRN mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vamp8 |
vesicle-associated membrane protein 8 |
increases expression |
ISO |
clothianidin results in increased expression of VAMP8 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:104,442,383...104,452,884
Ensembl chr 4:104,442,393...104,452,897
|
|
G |
Vegfd |
vascular endothelial growth factor D |
decreases expression |
ISO |
clothianidin results in decreased expression of VEGFD mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|
G |
Vps8 |
VPS8 subunit of CORVET complex |
decreases expression |
ISO |
clothianidin results in decreased expression of VPS8 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr11:79,402,236...79,634,234
Ensembl chr11:79,402,239...79,634,133
|
|
G |
Washc4 |
WASH complex subunit 4 |
increases expression |
ISO |
clothianidin results in increased expression of WASHC4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 7:20,187,905...20,240,228
Ensembl chr 7:20,187,922...20,240,226
|
|
G |
Whrn |
whirlin |
increases expression |
ISO |
clothianidin results in increased expression of WHRN mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 5:76,828,308...76,911,945
Ensembl chr 5:76,828,301...76,912,223
|
|
G |
Wnt7b |
Wnt family member 7B |
decreases expression |
ISO |
clothianidin results in decreased expression of WNT7B mRNA |
CTD |
PMID:35690182 |
|
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
|
|
G |
Ypel2 |
yippee-like 2 |
increases expression |
ISO |
clothianidin results in increased expression of YPEL2 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:71,746,308...71,803,843
Ensembl chr10:71,746,311...71,803,911
|
|
G |
Ypel3 |
yippee-like 3 |
decreases expression |
ISO |
clothianidin results in decreased expression of YPEL3 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr 1:181,384,385...181,387,706
Ensembl chr 1:181,384,357...181,387,705
|
|
G |
Zbtb45 |
zinc finger and BTB domain containing 45 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZBTB45 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:73,634,895...73,639,802
Ensembl chr 1:73,635,448...73,639,556
|
|
G |
Zcchc13 |
zinc finger CCHC-type containing 13 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZCCHC13 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr X:68,643,568...68,644,671
Ensembl chr X:68,643,549...68,665,131
|
|
G |
Zfp18 |
zinc finger protein 18 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZNF18 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr10:50,473,428...50,495,707
Ensembl chr10:50,473,483...50,495,706
|
|
G |
Zfp219 |
zinc finger protein 219 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZNF219 mRNA |
CTD |
PMID:29044138 |
|
NCBI chr15:24,695,831...24,710,039
Ensembl chr15:24,695,837...24,710,030
|
|
G |
Zfp467 |
zinc finger protein 467 |
increases expression |
ISO |
clothianidin results in increased expression of ZNF467 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
|
|
G |
Zfp470 |
zinc finger protein 470 |
increases expression |
ISO |
clothianidin results in increased expression of ZNF470 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:91,063,905...91,111,883
Ensembl chr 1:91,087,361...91,112,065
|
|
G |
Zfp502 |
zinc finger protein 502 |
increases expression |
ISO |
clothianidin results in increased expression of ZNF502 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:28,884,390...28,908,726
|
|
G |
Zfp521 |
zinc finger protein 521 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZNF521 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr18:4,775,952...5,068,592
Ensembl chr18:4,787,295...5,068,458
|
|
G |
Zfp653 |
zinc finger protein 653 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZNF653 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:20,586,607...20,605,439
Ensembl chr 8:20,586,563...20,604,864
|
|
G |
Zfp865 |
zinc finger protein 865 |
increases expression |
ISO |
clothianidin results in increased expression of ZNF784 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 1:68,805,302...68,809,780
Ensembl chr 1:68,805,302...68,809,780
|
|
G |
Zkscan7 |
zinc finger with KRAB and SCAN domains 7 |
increases expression |
ISO |
clothianidin results in increased expression of ZKSCAN7 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr 8:122,501,938...122,519,600
Ensembl chr 8:122,502,218...122,519,600
|
|
G |
Zswim4 |
zinc finger, SWIM-type containing 4 |
decreases expression |
ISO |
clothianidin results in decreased expression of ZSWIM4 mRNA |
CTD |
PMID:31626844 |
|
NCBI chr19:23,927,845...23,952,970
Ensembl chr19:23,927,845...23,952,970
|
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
dinotefuran results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]; dinotefuran results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein] |
CTD |
PMID:16981889 PMID:25459289 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
|
G |
1700012B07Rkl |
RIKEN cDNA 1700012B07 gene like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of 1700012B07RKL gene |
CTD |
PMID:33854195 |
|
NCBI chr10:94,771,471...94,804,839
Ensembl chr10:94,771,554...94,804,839
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
multiple interactions |
ISO |
[imidacloprid co-treated with Dietary Fats] results in increased expression of ACACB mRNA |
CTD |
PMID:33487623 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Ache |
acetylcholinesterase |
increases activity increases expression |
EXP |
imidacloprid results in increased activity of ACHE protein imidacloprid results in increased expression of ACHE protein |
CTD |
PMID:18080902 PMID:26024013 PMID:37648049 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ACOT2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACOT4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression decreases expression |
ISO |
imidacloprid results in increased expression of ACOX1 mRNA imidacloprid results in decreased expression of ACOX1 mRNA |
CTD |
PMID:33487623 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acy1 |
aminoacylase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAM15 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adcy6 |
adenylate cyclase 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ADRM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AFP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AGT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects expression |
ISO |
imidacloprid affects the expression of AHR mRNA |
CTD |
PMID:35457321 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aig1 |
androgen-induced 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of AIG1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
|
|
G |
Akap8 |
A-kinase anchoring protein 8 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
|
|
G |
Akap8l |
A-kinase anchoring protein 8 like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
|
|
G |
Alb |
albumin |
multiple interactions decreases expression |
EXP |
[imidacloprid co-treated with sodium arsenate] results in decreased expression of ALB protein imidacloprid results in decreased expression of ALB protein |
CTD |
PMID:30033815 PMID:34993831 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALG2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:61,768,738...61,773,297
Ensembl chr 5:61,768,740...61,773,297
|
|
G |
Ampd1 |
adenosine monophosphate deaminase 1 |
decreases expression |
EXP |
imidacloprid results in decreased expression of AMPD1 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 2:190,598,707...190,619,938
Ensembl chr 2:190,598,700...190,619,938
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Anks3 |
ankyrin repeat and sterile alpha motif domain containing 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:10,614,953...10,635,815
Ensembl chr10:10,615,047...10,635,806
|
|
G |
Anxa11 |
annexin A11 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:1,412,373...1,457,814
Ensembl chr16:1,410,756...1,457,797
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
affects methylation multiple interactions |
ISO |
imidacloprid affects the methylation of APC promoter LIF protein affects the reaction [imidacloprid affects the methylation of APC promoter] |
CTD |
PMID:33865946 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Aplf |
aprataxin and PNKP like factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APLF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Apof |
apolipoprotein F |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APOF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
|
|
G |
Ar |
androgen receptor |
decreases expression affects expression |
ISO |
imidacloprid results in decreased expression of AR mRNA; imidacloprid results in decreased expression of AR protein imidacloprid affects the expression of AR mRNA |
CTD |
PMID:31780179 PMID:35457321 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arf2 |
ADP-ribosylation factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ARF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ARPC1A gene |
CTD |
PMID:33854195 |
|
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
|
|
G |
Asb7 |
ankyrin repeat and SOCS box-containing 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:120,222,835...120,267,411
Ensembl chr 1:120,222,745...120,267,282
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ASS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atosa |
atos homolog A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ATOSA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BAG3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Banp |
Btg3 associated nuclear protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
imidacloprid results in increased expression of BAX mRNA; imidacloprid results in increased expression of BAX protein Thymol inhibits the reaction [imidacloprid results in increased expression of BAX mRNA] |
CTD |
PMID:27914857 PMID:34171690 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
increases activity |
EXP |
imidacloprid results in increased activity of BCHE protein |
CTD |
PMID:18080902 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
EXP |
imidacloprid results in decreased expression of BCL2 mRNA Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl9 |
BCL9, transcription coactivator |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of BCL9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:184,760,616...184,846,261
Ensembl chr 2:184,760,618...184,786,435
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BHMT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
C1qc |
complement C1q C chain |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C8H11ORF54 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
increases expression |
EXP |
imidacloprid results in increased expression of CACNA1H mRNA |
CTD |
PMID:27782041 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Cacng1 |
calcium voltage-gated channel auxiliary subunit gamma 1 |
decreases expression |
EXP |
imidacloprid results in decreased expression of CACNG1 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr10:92,652,924...92,665,612
Ensembl chr10:92,652,614...92,665,783
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAMK2G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2 |
decreases expression multiple interactions |
ISO |
imidacloprid results in decreased expression of CAMKK2 protein Dietary Fats promotes the reaction [imidacloprid results in decreased expression of CAMKK2 protein] |
CTD |
PMID:27960282 |
|
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Caps2 |
calcyphosine 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAPS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:47,580,636...47,641,598
Ensembl chr 7:47,581,137...47,639,229
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
imidacloprid results in increased expression of CASP3 mRNA; imidacloprid results in increased expression of CASP3 protein Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 mRNA]; Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 protein] |
CTD |
PMID:34171690 PMID:34993831 PMID:37648049 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases activity multiple interactions decreases expression |
EXP |
imidacloprid results in decreased activity of CAT protein imidacloprid promotes the reaction [sodium arsenate results in decreased activity of CAT protein]; Plant Extracts inhibits the reaction [imidacloprid results in decreased expression of CAT protein]; sodium arsenate promotes the reaction [imidacloprid results in decreased activity of CAT protein]; Thymol inhibits the reaction [imidacloprid results in decreased activity of CAT protein] |
CTD |
PMID:20686345 PMID:30033815 PMID:30456172 PMID:34171690 PMID:35398170 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbs |
cystathionine beta synthase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CBS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccdc125 |
coiled-coil domain containing 125 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
|
|
G |
Ccdc81 |
coiled-coil domain containing 81 |
increases expression |
EXP |
imidacloprid results in increased expression of CCDC81 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 1:143,739,472...143,791,026
Ensembl chr 1:143,739,474...143,790,926
|
|
G |
Ccnl1 |
cyclin L1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCNL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
|
|
G |
Cd36 |
CD36 molecule |
increases expression multiple interactions |
ISO |
imidacloprid results in increased expression of CD36 mRNA [imidacloprid co-treated with Dietary Fats] results in decreased expression of CD36 mRNA; [imidacloprid co-treated with Dietary Fats] results in increased expression of CD36 mRNA |
CTD |
PMID:27960282 PMID:33487623 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions affects methylation |
ISO |
LIF protein affects the reaction [imidacloprid affects the methylation of CDH1 promoter] |
CTD |
PMID:33865946 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CDKN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
affects methylation multiple interactions |
ISO |
imidacloprid affects the methylation of CDKN2A promoter LIF protein affects the reaction [imidacloprid affects the methylation of CDKN2A promoter] |
CTD |
PMID:33865946 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CEBPD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Celf6 |
CUGBP, Elav-like family member 6 |
increases expression |
EXP |
imidacloprid results in increased expression of CELF6 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 8:59,975,095...60,006,060
Ensembl chr 8:59,975,088...60,005,041
|
|
G |
Cep85 |
centrosomal protein 85 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CEP85 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:146,356,571...146,404,155
Ensembl chr 5:146,356,576...146,404,060
|
|
G |
Cerk |
ceramide kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
|
|
G |
Cfb |
complement factor B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfl1 |
cofilin 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CHCHD10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CHEK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
increases expression |
EXP |
imidacloprid results in increased expression of CHRM1 mRNA |
CTD |
PMID:26568164 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
increases expression |
EXP |
imidacloprid results in increased expression of CHRM2 protein |
CTD |
PMID:18080902 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrna1 |
cholinergic receptor nicotinic alpha 1 subunit |
multiple interactions |
EXP |
imidacloprid results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]; LYNX1 protein promotes the reaction [imidacloprid results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; LYPD1 protein promotes the reaction [imidacloprid results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] |
CTD |
PMID:19619141 |
|
NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
ISO |
imidacloprid results in increased activity of [CHRNA3 protein binds to CHRNB4 protein] |
CTD |
PMID:34628512 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
EXP ISO |
imidacloprid analog inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; imidacloprid binds to [CHRNA4 protein co-treated with CHRNB2 protein] imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB4 protein] |
CTD |
PMID:10377228 PMID:10728888 PMID:21538459 PMID:34628512 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
increases activity |
ISO |
imidacloprid metabolite results in increased activity of CHRNA7 protein; imidacloprid results in increased activity of CHRNA7 protein |
CTD |
PMID:34628512 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP ISO |
[NACHRA8 protein co-treated with CHRNB2 protein] affects the susceptibility to imidacloprid; imidacloprid analog inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; imidacloprid binds to [CHRNA4 protein co-treated with CHRNB2 protein]; imidacloprid binds to [NACHRALPHA1 protein co-treated with CHRNB2 protein]; imidacloprid binds to [NACHRALPHA2 protein co-treated with CHRNB2 protein]; imidacloprid binds to [NACHRALPHA3 protein co-treated with CHRNB2 protein]; imidacloprid results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]; imidacloprid results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]; imidacloprid results in increased activity of [NACHRALPHA1 protein co-treated with CHRNB2 protein]; imidacloprid results in increased activity of [NACHRALPHA1 protein co-treated with NACHRALPHA2 protein co-treated with CHRNB2 protein]; imidacloprid results in increased activity of [NACHRALPHA2 protein co-treated with CHRNB2 protein]; LYNX1 protein promotes the reaction [imidacloprid results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]]; LYPD1 protein promotes the reaction [imidacloprid results in increased activity of [CHRNA1 protein binds to CHRNB2 protein]] imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:10377228 PMID:10728888 PMID:16291090 PMID:16981889 PMID:18824080 PMID:19046356 PMID:19619141 PMID:19849723 PMID:21538459 PMID:25459289 PMID:25613467 PMID:34628512 More...
|
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
multiple interactions |
ISO |
imidacloprid results in increased activity of [CHRNA3 protein binds to CHRNB4 protein]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB4 protein] |
CTD |
PMID:34628512 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
multiple interactions |
ISO |
[imidacloprid co-treated with Dietary Fats] results in increased expression of CIDEA mRNA |
CTD |
PMID:33487623 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cirbp |
cold inducible RNA binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CIRBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
imidacloprid results in decreased expression of CLDN1 mRNA |
CTD |
PMID:27792329 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CLU mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crb3 |
crumbs cell polarity complex component 3 |
increases expression |
EXP |
imidacloprid results in increased expression of CRB3 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 9:1,898,531...1,903,860
Ensembl chr 9:1,896,623...1,903,859
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CRY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSPP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of CTH gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
|
|
G |
Ctnnd1 |
catenin delta 1 |
increases expression |
EXP |
imidacloprid results in increased expression of CTNND1 mRNA |
CTD |
PMID:27792329 |
|
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
ISO EXP |
imidacloprid results in decreased expression of CYP11A1 mRNA Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:31780179 PMID:34171690 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP ISO |
imidacloprid results in decreased expression of CYP17A1 mRNA Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:27782041 PMID:31780179 PMID:34171690 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases activity multiple interactions affects expression decreases expression |
ISO EXP |
imidacloprid results in increased activity of CYP19A1 protein 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione affects the reaction [imidacloprid affects the expression of CYP19A1 mRNA] Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP19A1 mRNA] |
CTD |
PMID:28750898 PMID:29701941 PMID:34171690 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
imidacloprid results in increased expression of CYP2B10 mRNA |
CTD |
PMID:36320626 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
EXP |
imidacloprid results in increased expression of CYP2E1 mRNA |
CTD |
PMID:37632782 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[NADP co-treated with CYP3A4 protein] results in increased activity of imidacloprid analog |
CTD |
PMID:16153789 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
EXP |
imidacloprid results in increased expression of CYP4F18 mRNA |
CTD |
PMID:37632782 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Cytip |
cytohesin 1 interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CYTIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dclre1c |
DNA cross-link repair 1C |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DCLRE1C mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186
|
|
G |
Ddx20 |
DEAD-box helicase 20 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX20 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:193,158,761...193,168,484
Ensembl chr 2:193,158,823...193,166,774
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DFFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DLG2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DLL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dmrt3 |
doublesex and mab-3 related transcription factor 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:223,244,340...223,264,254
Ensembl chr 1:223,248,747...223,262,530
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DPP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dzip1l |
DAZ interacting zinc finger protein 1-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DZIP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 8:100,188,414...100,229,077
Ensembl chr 8:100,194,999...100,228,988
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
multiple interactions |
ISO |
[imidacloprid co-treated with Dietary Fats] results in increased expression of ELOVL6 mRNA |
CTD |
PMID:33487623 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of EMILIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ENPP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Epm2aip1 |
EPM2A interacting protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of EPM2AIP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
|
|
G |
Erf |
Ets2 repressor factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ERF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:80,829,935...80,838,388
Ensembl chr 1:80,829,935...80,838,388
|
|
G |
Esd |
esterase D |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ESD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Esr1 |
estrogen receptor 1 |
increases expression |
ISO |
imidacloprid results in increased expression of ESR1 mRNA |
CTD |
PMID:35457321 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects expression |
ISO |
imidacloprid affects the expression of ESR2 mRNA |
CTD |
PMID:35457321 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
increases expression |
EXP |
imidacloprid results in increased expression of F2RL2 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
[imidacloprid co-treated with Dietary Fats] results in decreased expression of FABP4 mRNA |
CTD |
PMID:33487623 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fam135a |
family with sequence similarity 135, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:26,420,116...26,500,803
Ensembl chr 9:26,420,528...26,500,717
|
|
G |
Fam177a1 |
family with sequence similarity 177, member A1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:72,632,628...72,647,553
Ensembl chr 6:72,632,623...72,647,553
|
|
G |
Fam204a |
family with sequence similarity 204, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:259,328,551...259,366,726
Ensembl chr 1:259,337,709...259,367,077
|
|
G |
Fam53a |
family with sequence similarity 53, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM53A gene |
CTD |
PMID:33854195 |
|
NCBI chr14:77,088,178...77,124,395
Ensembl chr14:77,090,723...77,124,395
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
[imidacloprid co-treated with Dietary Fats] results in increased expression of FAS mRNA |
CTD |
PMID:33487623 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Ficd |
FIC domain protein adenylyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FICD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FKBP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fmn1 |
formin 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FMN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
|
|
G |
Frmd4b |
FERM domain containing 4B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FRMD4B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions increases expression |
EXP |
Thymol inhibits the reaction [imidacloprid results in increased expression of FSHB protein] |
CTD |
PMID:34171690 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fzd6 |
frizzled class receptor 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FZD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Galnt7 |
polypeptide N-acetylgalactosaminyltransferase 7 |
increases expression |
EXP |
imidacloprid results in increased expression of GALNT7 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr16:32,578,643...32,703,189
Ensembl chr16:32,578,690...32,702,690
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
imidacloprid results in increased expression of GFAP protein |
CTD |
PMID:18080902 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gin1 |
gypsy retrotransposon integrase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
|
|
G |
Git2 |
GIT ArfGAP 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression |
EXP |
imidacloprid results in decreased expression of GJA1 mRNA |
CTD |
PMID:27792329 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:38,520,663...38,538,713
Ensembl chr14:38,520,705...38,538,713
|
|
G |
Gprasp3 |
G protein-coupled receptor associated sorting protein family member 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:98,847,591...98,854,949
Ensembl chr X:98,817,593...98,854,545
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions increases expression |
EXP ISO |
imidacloprid results in increased activity of GPT protein [imidacloprid co-treated with sodium arsenate] results in increased activity of GPT protein [imidacloprid co-treated with fipronil co-treated with Glyphosate] results in increased activity of and results in increased secretion of GPT protein imidacloprid results in increased expression of GPT protein [imidacloprid co-treated with Dietary Fats] results in increased expression of GPT protein |
CTD |
PMID:30033815 PMID:33487623 PMID:34993831 PMID:35850439 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gramd1a |
GRAM domain containing 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GRAMD1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:86,367,001...86,393,348
Ensembl chr 1:86,367,001...86,393,336
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GRIA1 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GRINA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Gsdma |
gasdermin A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GSDMA gene |
CTD |
PMID:33854195 |
|
NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
EXP |
imidacloprid promotes the reaction [sodium arsenate results in decreased activity of GSR protein]; sodium arsenate promotes the reaction [imidacloprid results in decreased activity of GSR protein] |
CTD |
PMID:30033815 PMID:30456172 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GSTK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Hao1 |
hydroxyacid oxidase 1 |
decreases expression |
EXP |
imidacloprid results in decreased expression of HAO1 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 3:121,757,400...121,828,721
Ensembl chr 3:121,771,836...121,828,721
|
|
G |
Hapstr2 |
HUWE1 associated protein modifying stress responses 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of HAPSTR2 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:138,922,089...138,924,124
Ensembl chr X:138,922,100...138,922,918
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
|
|
G |
Hebp1 |
heme binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HES1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
decreases expression |
EXP |
imidacloprid results in decreased expression of HJV mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
imidacloprid results in decreased expression of HMGCR mRNA |
CTD |
PMID:31780179 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
imidacloprid results in increased expression of HMOX1 mRNA |
CTD |
PMID:34993831 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hs3st3b1 |
heparan sulfate-glucosamine 3-sulfotransferase 3B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HS3ST3B1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD17B10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HSD17B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions decreases expression |
EXP |
Thymol inhibits the reaction [imidacloprid results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
decreases expression |
EXP |
imidacloprid results in decreased expression of HSD3B2 mRNA |
CTD |
PMID:27914857 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
decreases expression |
ISO |
imidacloprid results in decreased expression of HSP90B1 protein |
CTD |
PMID:16884889 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
imidacloprid results in decreased expression of HSPA5 protein |
CTD |
PMID:16884889 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
ISO |
imidacloprid results in decreased expression of HSPB1 protein |
CTD |
PMID:16884889 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspb7 |
heat shock protein family B (small) member 7 |
decreases expression |
EXP |
imidacloprid results in decreased expression of HSPB7 mRNA |
CTD |
PMID:27782041 |
|
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
|
|
G |
Hspbp1 |
HSPA (Hsp70) binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:69,165,394...69,189,062
Ensembl chr 1:69,165,572...69,244,593
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
increases expression |
EXP |
imidacloprid results in increased expression of HTR2C mRNA |
CTD |
PMID:27782041 |
|
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifna12l |
interferon alpha 12 like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IFNA12L gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:103,476,362...103,477,427
Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igkv2-112l2 |
immunoglobulin kappa variable 2-112 like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IGKV2-112L2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:102,208,069...102,208,647
Ensembl chr 4:102,208,044...102,208,785
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression |
EXP |
Plant Extracts inhibits the reaction [imidacloprid results in decreased expression of IL10 mRNA] |
CTD |
PMID:35398170 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP ISO |
imidacloprid results in increased expression of IL1B mRNA Plant Extracts inhibits the reaction [imidacloprid results in increased expression of IL1B mRNA] [imidacloprid co-treated with Dietary Fats] results in decreased expression of IL1B mRNA |
CTD |
PMID:33487623 PMID:35398170 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP ISO |
Plant Extracts inhibits the reaction [imidacloprid results in increased expression of IL6 mRNA] [imidacloprid co-treated with Dietary Fats] results in decreased expression of IL6 mRNA |
CTD |
PMID:33487623 PMID:35398170 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,190,480...183,270,276
Ensembl chr 1:183,190,480...183,270,276
|
| |